Study of the Therapeutic Effects of Intercessory Prayer (STEP): study design and research methods

Authors
Jeffrey A. Dusek, PhD, Jane B. Sherwood, RN, BSN, Richard Friedman, PhD, Patricia Myers, BA, Charles F. Bethea, MD, Sidney Levitsky, MD, Peter C. Hill, MD, Manoj K. Jain, MD, Stephen L. Kopecky, MD, Paul S. Mueller, MD, Peter Lam, PhD, Herbert Benson, MD, Patricia L. Hibberd, MD, PhD
Publication
American Heart Journal
143(4):577-584
Abstract

Background: The effect of intercessory prayer (IP) on outcome in cardiac cases has been evaluated previously, but results are controversial. The goals of the Study of the Therapeutic Effects of Intercessory Prayer (STEP) are to evaluate the effects of receipt of additional study IP and awareness of receipt of additional study IP on outcomes in patients undergoing coronary artery bypass graft surgery. STEP is not designed to determine whether God exists or whether God does or does not respond to IP.

Methods: STEP is a multicenter, controlled trial of 1802 patients in 6 US hospitals, randomized to 1 of 3 groups. Two groups were informed that they may or may not receive 14 consecutive days of additional IP starting the night before coronary artery bypass graft surgery; Group 1 received IP, Group 2 did not. A third group (Group 3) was informed that they would receive additional IP and did so. Three mainstream religious sites provided daily IP for patients assigned to receive IP. At each hospital, research nurses blinded to patient group assignment reviewed medical records to determine whether complications occurred, on the basis of the Society for Thoracic Surgeons definitions. A blinded nurse auditor from the Coordinating Center reviewed every study patient’s data against the medical record before release of study forms.

Results: The STEP Data and Safety Monitoring Board reviewed patient safety and outcomes in the first 900 study patients. Patients were enrolled in STEP from January 1998 to November 2000.

Related Listings
Heart Rate Variability and Perceived Stress as ...
Authors
Mutsuhiro Nakao
Journal
Journal of Clinical Medicine
Stress is a term used to define the body’s physiological and psychological reactions to circumstances that require behavioral adjustment [1,2,3], and the relaxation response is a psychophysiological state that is opposite to that of the stress or fight–flight response [4]. A variety of mind/body techniques can be used to elicit a relaxation response and achieve the therapeutic effects associated with reduced blood pressure. For example, researchers at the Cochrane Review [5] investiga […]
Meditation and Cardiovascular Risk Reduction: A...
Authors
Glenn N. Levine, Richard A. Lange, C. Noel Bairey-Merz
Journal
Journal of the American Heart Association
Provides 37 pages of summaries from decades of research concerning how meditation affects heart related functioning (blood pressure, heart rate, etc.) Abstract Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the […]
Specific Transcriptome Changes Associated with ...
Authors
Manoj K. Bhasin, PhD, John W. Denninger, MD, PhD, Jeff C. Huffman, MD, Marie G. Joseph, BA, Halsey Niles, BA, Emma Chad-Friedman, BA, Robert Goldman, BA, Beverly Buczynski-Kelley, RN, Barbara A. Mahoney, RN, Gregory L. Fricchione, MD, Jeffery A. Dusek, PhD, Herbert Benson, MD, Randall M. Zusman, MD, Towia A. Liebermann, PhD
Journal
Journal Alternative and Complementary Medicine
Objective: Mind–body practices that elicit the relaxation response (RR) have been demonstrated to reduce blood pressure (BP) in essential hypertension (HTN) and may be an adjunct to antihypertensive drug therapy. However, the molecular mechanisms by which the RR reduces BP remain undefined. Design: Genomic determinants associated with responsiveness to an 8-week RR-based mind–body intervention for lowering HTN in 13 stage 1 hypertensive patients classified as BP responders and 11 as n […]